Hiroaki Yanagimoto

11PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInfant and child healthCancer diagnosisLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 12, 2026
Impact of Borderline Resectable Criteria on Hepatocellular Carcinoma Treatment From the Perspective of Tumor Burden.

Shohei Komatsu, Toshifumi Tada, Nobuaki Ishihara

|Mar 09, 2026
Learning Curve Effect in Reducing Local Recurrence Rate After Resection of Pancreatic Cancer With Arterial Abutment: A Single-Center Retrospective Study.

Jun Ishida, Hirochika Toyama, Takayuki Kodama

|Jan 27, 2026
Original Study: Risk Factors for Early Recurrence in Patients With Biliary Tract Cancers Who Underwent Curative Resection: An Exploratory Subgroup Analysis of JCOG1202.

Hiroaki Yanagimoto, Kohei Nakachi, Masafumi Ikeda

|Nov 20, 2025
Laparoscopic cholecystectomy for double gallbladder with the accessory cystic duct draining into the main pancreatic duct.

Yuki Okazoe, Hiroaki Yanagimoto, Daisuke Tsugawa

|Nov 11, 2025
Utility of Oncological Resectability Criteria in Recurrent Hepatocellular Carcinoma After Hepatectomy.

Nobuaki Ishihara, Shohei Komatsu, Toshifumi Tada

|Nov 07, 2025
Prognostic Significance of GLIM-Defined Malnutrition in Patients With Resectable Pancreatic Adenocarcinoma Following Upfront Surgery.

Takuya Mizumoto, Yoshihide Nanno, Jun Ishida

Pageof 2

Frequent Collaborators

7 joint publications

Shohei Komatsu

3 joint publications

Takumi Fukumoto

2 joint publications

Takuya Mizumoto

2 joint publications

Yoshihide Nanno